- Home
- TELO vs TNYA Comparison
TELO vs TNYA Comparison
Compare TELO & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- TNYA
- Stock Information
- Founded
- TELO 2021
- TNYA 2016
- Country
- TELO United States
- TNYA United States
- Employees
- TELO N/A
- TNYA N/A
- Industry
- TELO
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- TELO
- TNYA Health Care
- Exchange
- TELO NYSE
- TNYA Nasdaq
- Market Cap
- TELO 124.1M
- TNYA 138.1M
- IPO Year
- TELO 2024
- TNYA 2021
- Fundamental
- Price
- TELO $4.91
- TNYA $1.41
- Analyst Decision
- TELO
- TNYA Strong Buy
- Analyst Count
- TELO 0
- TNYA 4
- Target Price
- TELO N/A
- TNYA $17.33
- AVG Volume (30 Days)
- TELO 256.6K
- TNYA 6.8M
- Earning Date
- TELO 11-12-2024
- TNYA 11-06-2024
- Dividend Yield
- TELO N/A
- TNYA N/A
- EPS Growth
- TELO N/A
- TNYA N/A
- EPS
- TELO N/A
- TNYA N/A
- Revenue
- TELO N/A
- TNYA N/A
- Revenue This Year
- TELO N/A
- TNYA N/A
- Revenue Next Year
- TELO N/A
- TNYA N/A
- P/E Ratio
- TELO N/A
- TNYA N/A
- Revenue Growth
- TELO N/A
- TNYA N/A
- 52 Week Low
- TELO $3.11
- TNYA $0.99
- 52 Week High
- TELO $20.72
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- TELO 50.38
- TNYA 31.02
- Support Level
- TELO $4.35
- TNYA $2.56
- Resistance Level
- TELO $5.39
- TNYA $3.69
- Average True Range (ATR)
- TELO 0.69
- TNYA 0.46
- MACD
- TELO -0.00
- TNYA -0.19
- Stochastic Oscillator
- TELO 32.62
- TNYA 14.00
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.